Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory DisordersDavid Harrison, Alan P. Watt, John R. Doedens et al.|Journal of Medicinal Chemistry|2023Cited by 62
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Alan P. Watt, Mark G. Bock et al.|ACS Medicinal Chemistry Letters|2022Cited by 23
Profile of NT-0527, a brain penetrant NLRP3 Inflammasome inhibitor suitable as an <i>in vivo</i> tool compound for neuroinflammatory disordersDavid Harrison, Alan P. Watt, Andy Billinton et al.|RSC Medicinal Chemistry|2025Cited by 3